Patent classifications
A61B5/6873
ANORECTAL BIOFEEDBACK DEVICE
A pressure sensing device including an elongate housing configured to be at least partially inserted into a user, and that defines an external surface having a proximal end and a distal end defining a longitudinal axis therebetween. The device includes a first pressure sensor, configured to sense pressure applied to a first portion of the external surface and to convert the sensed pressure to first pressure data, and a second pressure sensor, configured to sense pressure applied to a second portion of the external surface and to convert the sensed pressure to second pressure data. Sensor is spaced, along the longitudinal axis, toward the distal end from sensor.
Devices for testing distal colonic and anorectal function
A pellet for testing distal colonic and anorectal function. In one embodiment the pellet comprises a bag comprising the exterior of the pellet wherein the bag is comprised of a polymer that is reactive with a catalyst to form a more solid-like substance. In another embodiment, the pellet may comprise one of a grapheme layer, a wavelength transducer, or a magnetically attractive element. In another embodiment the pellet may comprise a telescopic extender and further comprise a telescope bad coupled to the telescopic extender.
Flexible piezoelectric devices for gastrointestinal motility sensing
Improvements in ingestible electronics with the capacity to sense physiologic and pathophysiologic states have transformed the standard of care for patients. Yet despite advances in device development, significant risks associated with solid, non-flexible gastrointestinal transiting systems remain. Here, we disclose an ingestible, flexible piezoelectric device that senses mechanical deformation within the gastric cavity. We demonstrate the capabilities of the sensor in both in vitro and ex vivo simulated gastric models, quantified its key behaviors in the GI tract by using computational modeling, and validated its functionality in awake and ambulating swine. Our piezoelectric devices can safely sense mechanical variations and harvest mechanical energy inside the gastrointestinal tract for diagnosing and treating motility disorders and for monitoring ingestion in bariatric applications.
System and method for an ingestible physiological monitor
In accordance with some non-limiting examples of the disclosed subject matter, an ingestible system configured to acquire physiological information from an interior of a subject is provided, comprising a substrate and at least one physiological sensor. The at least one “physiological sensor can be coupled to the substrate and configured to capture physiological data from at least one of an internal area or an orientation in a digestive tract of the subject. The system can include a controller coupled to the substrate and configured to receive the physiological data and prepare the physiological data for one of transmission from the subject or analysis of the physiological data. The substrate, including the at least one physiological sensor and the controller coupled thereto can be configured to self-orient within the digestive tract of the subject, during ingestion of the system by the subject.
LAPAROSCOPIC BOWEL LENGTH INDICATING DEVICES AND METHODS OF USE
A measuring device and methods of use for measuring a section of a bowel of a patient. The measuring device includes a tubular section having a longitudinal axis and at least one wing normally projecting outward transverse to the longitudinal axis. The tubular section is configured for mounting on a conventional or robotic laparoscopic grasper adjacent the grasper's movable jaws. The at least one wing is are pivotable to a closed position so that grasper with the measuring device mounted thereon can be inserted through a conventional trocar, whereupon the at least one wing projects outward transversely to the longitudinal axis. The at least one wing is of a predetermined length to serve as a measurement tool enabling a surgeon to measure off a desired length of the bowel.
IMPEDANCE MANOMETRY DEVICE FOR QUANTIFIABLE DIAGNOSIS OF PELVIC PROLAPSE
A system for diagnosing and quantifying an organ prolapse includes a first manometry catheter configured for insertion within a first organ of the pelvic floor. The first manometry catheter includes an inflatable balloon configured to support a series of first sensors disposed along a length thereof and operably coupled to an image display for displaying a first image thereon relating to the first organ. One or more additional manometry catheters are configured for insertion within one or more respective additional organs. The additional manometry catheters include inflatable balloons configured to support corresponding additional sensors along a length thereof. The additional sensors are operably coupled to the image display for displaying one or more additional images thereon relating to the one or more additional organs. The first image and the one or more additional images being simultaneously displayed on the image display for diagnostic and quantification purposes.
Method to assess pelvic floor muscles injury, and probe and apparatus to implement the method
The object of the present invention is the method to assess the pelvic floor muscle injury, comprising the steps of applying the measuring probe into the anus, generation of electric current signals of constant amplitude, using a current generator, and applying the signals into the pelvic floor muscles by means of application electrodes (EA1) and (EA2), detection of electric voltage signals from the pelvic floor muscles by means of a plurality of measuring electrodes (EP1), EP2 . . . EPn, analysis of electric current and voltage signals for amplitude values and phase dependencies of their waveform, wherein the electric current signals and the electric voltage signals from the pelvic bottom muscles constitute signals variable in time, of the frequencies ranging from 2 kHz to 200 kHz. The object of the invention is also an electrode based measuring probe and apparatus implementing the method of assessment pelvic floor muscles injury.
System and method for performing translumbosacral neuromodulation therapy in a subject
A system and method which performs translumbosacral neuromodulation therapy in a subject by outputting pulses of magnetic energy onto the lumbar and sacral nerves of the subject is described. The system includes a control unit, an anorectal probe, at least one skin electrode, a first magnetic coil, a second magnetic coil, and a neurophysiological recorder. The control unit manages the system components. The anorectal probe and the skin electrode detect muscle activity when a nerve from the back of the subject is stimulated. The first magnetic coil outputs singular pulses of magnetic energy to localize a plurality of optimal stimulation sites. The second magnetic coil outputs repetitive pulses of magnetic energy to each of the plurality of optimal stimulation sites in order to treat medical problems. The neurophysiological recorder displays motor-evoked potential (MEP) data that is detected by the anorectal probe and the skin electrode through electromyographic sensors.
SYSTEMS AND METHODS FOR POST-OPERATIVE ANASTOMOTIC LEAK DETECTION
A tissue monitoring system includes a sensor, a sensor reader, and at least one computing device. The sensor is releasably coupled to a staple by a tether and is configured to measure a physiological parameter of tissue and convert the measurement into a signal. The sensor reader is configured to receive the signal from the sensor and the at least one computing device is configured to receive the signal from the sensor reader and process the signal into physiological data. The sensor is implanted in tissue by the staple.
SYSTEMS AND METHODS FOR DELIVERING TARGETED THERAPY
A computer-assisted medical device is configured and used to endoluminally navigate to a location in the gastrointestinal system and there treat certain body lumen wall areas while avoiding other body lumen wall areas. Embodiments ablate the inner mucosal layer and sub-mucosal nerve plexus of the stomach, duodenum and jejunum to effect treatment of insulin resistance and metabolic disorders, such as Type II diabetes (T2D), polycystic ovarian syndrome (PCOS), non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), congestive heart failure (CHF) and obstructive sleep apnea (OSA). Various sensors are used to assist a clinical operator to navigate from the mouth through the pyloric sphincter and into and through the duodenum and/or jejunum. Various sensors are used to map and identify portions of the duodenum and/or jejunum. Various lumen wall ablation devices and methods are described. Various post-treatment assessments are described.